Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
2(20%)
Results Posted
86%(6 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
1
10%
Ph phase_2
3
30%
Ph not_applicable
5
50%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
3(33.3%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (11.1%)
Phase 23 (33.3%)
N/A5 (55.6%)

Trials by Status

completed770%
recruiting220%
terminated110%

Recent Activity

2 active trials
Showing 5 of 10
recruitingnot_applicable

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

NCT06372899
recruitingnot_applicable

The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers

NCT06264154
completedphase_2

Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders

NCT04090879
completedphase_2

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder

NCT04092101
completednot_applicable

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

NCT04092387
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06372899Not Applicable

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

Recruiting
NCT06264154Not Applicable

The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers

Recruiting
NCT04090879Phase 2

Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders

Completed
NCT04092101Phase 2

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder

Completed
NCT04092387Not Applicable

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

Completed
NCT02590393Phase 1

The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence

Completed
NCT03863509

E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease

Completed
NCT03492463Phase 2

The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products

Completed
NCT01800500Not Applicable

Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers

Terminated
NCT02628964Not Applicable

Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy

Completed

All 10 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
10